Filter
78
Text search:
falsified
drugs
Featured
Recommendations
8
New Publications
23
Language
Document type
No document type
23
Studies & Reports
16
Guidelines
13
Strategic & Response Plan
9
Manuals
7
Training Material
7
Situation Updates
1
Resource Platforms
1
Fact sheets
1
Countries / Regions
Uganda
4
Philippines
3
Eastern Europe and Central Asia
3
Western and Central Europe
3
Nigeria
2
Rwanda
2
Eswatini/ Swaziland
2
Global
2
Ethiopia
1
Ghana
1
Zimbabwe
1
India
1
Somalia
1
Nepal
1
Pakistan
1
Afghanistan
1
Kenya
1
Tanzania
1
Cambodia
1
Thailand
1
Bangladesh
1
Malawi
1
Ukraine
1
Libya
1
Myanmar / Burma
1
Africa
1
Venezuela
1
Authors & Publishers
Publication Years
Category
Countries
24
Pharmacy & Technologies
4
Public Health
2
Clinical Guidelines
2
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
AMR
24
Pharmacy
19
Mental Health
6
TB
3
Global Health Education
3
COVID-19
3
Planetary Health
2
Conflict
1
Natural Hazards
1
Specific Hazards
1
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Annex 5, WHO Technical Report Series 1010, 2018
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
Accessed: 22.03.2019
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an
...
Two test methods on dexamethasone tablets and injections
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer
...
An update from the EU Early Warning System
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
This Medical Product Alert relates to the recent circulation of two confirmed falsified versions of Quinine
Sulphate circulating in Cameroon and the Democratic Republic of the Congo, containing zero active
pharmaceutical ingredient
SITUATION ANALYSIS AND RECOMMENDATIONS
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development
...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
